Medindia

X

Natural Chelation Alternative Offers New, Non-Invasive Approach to Autism Spectrum Disorder Treatment

Saturday, January 30, 2010 General News J E 4
Advertisement


HOOD RIVER, Ore., Jan. 29 In a recent study released by the Center for Disease Control (CDC), autism has risen to an epidemic rate of 1 in 100 in the U.S., up from 1 in 150 in 2007. While controversy looms regarding its cause, many parents of autistic children believe a correlation exists with toxin accumulation. Until recently, chelation, an invasive, drug-based toxin removal therapy, has been parents' primary option. Today, autism spectrum disorder (ASD) sufferers have a natural alternative to chelation therapy with the introduction of Maxam Nutraceutics (www.maxamlabs.com) PCA-Rx.

While Chelation is commonly administered intravenously using the drug agents' dimercaptosuccine acid (DMSA) and dimercaptopropane sulfonate (DMPS), this heavy metal removal method has become increasingly under fire by parents concerned about side effects.

According to Tina Beeck, who switched from chelation to PCA-Rx for treating her 4-year-old autistic son Miller stated, "He went non-verbal and non-toilet trained every weekend we were chelating. We have been extremely pleased with PCA-Rx. We have seen tremendous cognitive gains - slowly at first and then dramatically. Sometimes he seems downright neuro-typical."

The result of years of rigorous research and development, PCA-Rx represents a breakthrough in toxin removal technology called Clathration Therapy. PCA-Rx is an epigenetic cell fermentation formula, comprised of helpful bacteria and other microbes that when used become a natural, living part of the body's immune system. Administered orally one to eight sprays per day under the tongue, it envelops, neutralizes and removes the harmful toxins through stool, urine, skin and breath without ever touching vital organs or tissue.

PCA-Rx helps eliminate heavy metals, chemical toxins and harmful parasite microorganisms; reduce cardio and cerebral vascular plaque; lower elevated enzyme counts; and decrease environmental illness effects.

PCA-Rx represents the next generation of chelation technology," explained Maxam Nutraceutics President James Cole. "We're thrilled to provide autism sufferers a natural, toxin removal treatment that's easy-to-use, powerful and with no known side effects."

PCA Rx is also used for Alzheimer's, candida, cervical dystonia, chemical exposure, heart disease, hepatitis, herpes, Lyme disease, paralysis, Nieman-Pick disease and uterine fibroids. It is available through www.maxamlabs.com.

For more information, or interview scheduling with James Cole, contact Renee Cooper, ChristieCommunications(www.christiecomm.com): (805) 962-1347, rcooper@christiecomm.com.

*PCA Rx has not been evaluated by the FDA and not intended to diagnose, treat, or cure any disease.

SOURCE Maxam Nutraceutics
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Pivotal Trial Results for Motavizumab Published in...
S
Doctors Tell Lawmakers to Find a New GAMC Fix